| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +3.7% |
| Cost of Revenue | $152.6M | +7.9% |
| Gross Profit | $1.15B | +3.1% |
| R&D Expense | $271.5M | +4.0% |
| SG&A Expense | $258.5M | -6.1% |
| Operating Income | $215.8M | +4.4% |
| Pre-tax Income | $250.1M | +16.2% |
| Income Tax | $48.4M | +54.3% |
| Net Income | $200.7M |
| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $745.4M | +20.2% |
| Short-term Investments | $139.1M | -26.5% |
| Accounts Receivable | $262.2M | +7.7% |
| Inventory | $35.6M | +51.3% |
| Current Assets | $1.49B | +13.5% |
| Total Assets | $2.98B | +10.8% |
| Current Liabilities | $422.2M | +52.1% |
| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $367.1M | +15.2% |
| Capital Expenditures | $30.3M | -36.7% |
| Investing Cash Flow | $54.2M | +118.3% |
| Financing Cash Flow | -$236.8M | +61.2% |
| Free Cash Flow | $336.7M | +24.4% |
| +9.0% |
| EPS (Basic) | $2.10 | +14.1% |
| EPS (Diluted) | $2.05 | +13.3% |
| Total Liabilities |
| $607.6M |
| +38.6% |
| Stockholders' Equity | $2.36B | +4.8% |